Načítá se...
Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies
Background Coeliac disease affects 1% of the population, but 75% remain undiagnosed. Objective To conduct a case finding feasibility and efficacy study for the detection of coeliac disease in community pharmacies. Setting Six community pharmacies across Sheffield, UK. Method A prospective study was...
Uloženo v:
| Vydáno v: | Int J Clin Pharm |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509084/ https://ncbi.nlm.nih.gov/pubmed/30778740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-019-00793-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|